Publications en infectiologie pulmonaire indexées PubMed (par année, catégories et ordre alphabétique)

Size: px
Start display at page:

Download "Publications en infectiologie pulmonaire indexées PubMed (par année, catégories et ordre alphabétique) 15.09.2012"

Transcription

1 Publications en infectiologie pulmonaire indexées PubMed (par année, catégories et ordre alphabétique) Communautaire Beigelman-Aubry C, Godet C, Caumes E. Lung infections: the radiologist's perspective. Diagn Interv Imaging Jun;93(6): Catherinot E. Pneumonia in elderly patient. Soins Gerontol Jul-Aug;(96):34-7. Durand-Maugard C, Lemaire-Hurtel AS, Gras-Champel V, Hary L, Maizel J, Prud'homme- Bernardy A, Andréjak C, Andréjak M. Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reports. J Antimicrob Chemother May;67(5): Gacouin A, Revest M, Letheulle J, Fillatre P, Jouneau S, Piau C, Uhel F, Tattevin P, Le Tulzo Y. Distinctive features between community-acquired pneumonia (CAP) due to Chlamydophila psittaci and CAP due to Legionella pneumophila admitted to the intensive care unit (ICU). Eur J Clin Microbiol Infect Dis Apr 28. [Epub ahead of print] Guerrier G, Goyet S, Chheng ET, Rammaert B, Borand L, Te V, Try PL, Sareth R, Cavailler P, Mayaud C, Guillard B, Vong S, Buchy P, Tarantola A. Acute Viral Lower Respiratory Tract Infections in Cambodian Children: Clinical and Epidemiological Characteristics. Pediatr Infect Dis J Aug 24. [Epub ahead of print] Obert J, Burgel PR. Pneumococcal infections: Association with asthma and COPD. Med Mal Infect Mar 21. [Epub ahead of print] Rammaert B, Goyet S, Beaute J, Hem S, Te V, Try PL, Mayaud C, Borand L, Buchy P, Guillard B, Vong S. Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: Clinical characteristics and treatment. BMC Infect Dis Jan 10;12(1):3. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, et al. Guidelines for the management of adult lower respiratory tract infections--full version. Clin. Microbiol. Infect nov;17 Suppl 6:E1 59. Infections / pathologie pulmonaire chronique Boucher MB, Bedotto M, Couderc C, Gomez C, Reynaud-Gaubert M, Drancourt M. Haemophilus pittmaniae respiratory infection in a patient with siderosis: a case report. J Med Case Rep Apr 30;6(1):120. Burgel PR, Baixench MT, Amsellem M, Audureau E, Chapron J, Kanaan R, Honoré I, Dupouy-Camet J, Dusser D, Klaassen CH, Meis JF, Hubert D, Paugam A. High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole. Antimicrob Agents Chemother Feb;56(2):

2 Jacques Cadranel, Bruno Philippe, Christophe Hennequin, Anne Bergeron, Emmanuel Bergot, Arnaud Bourdin, Vincent Cottin, Thierry Jeanfaivre, Cendrine Godet, Marc Pineau, Patrick Germaud. Voriconazole for chronic pulmonary aspergillosis: a multicenter phase II trial. Eur J Clin Microbiol Infect Dis Jul 11. [Epub ahead of print] Godet C, Meurice JC, Roblot F, Kauffmann-Lacroix C, Verdaguer M, Frat JP, Cadranel J. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA. Eur Respir J May;39(5): Foucaud P, Borel B, Charara O, Nathanson S, Petitprez P, Pin I. [Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin]. Rev Pneumol Clin Jun;58(3 Pt 1): Montaigne E, Petit FX, Gourdier AL, Urban T, Gagnadoux F. [Pulmonary aspergillosis complicating atypical mycobacterial infection in two patients suffering from chronic obstructive pulmonary disease]. Rev Mal Respir Jan;29(1): Immunodéprimés Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A, Cornet M, Isnard F, Raffoux E, Brethon B, Lacroix C, Touratier S, Latgé JP, Bouges-Michel C, Tazi A, Derouin F, Ribaud P, Sulahian A. Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients. J Clin Microbiol ;50(3) : Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E, Vekhoff A, Cornet M, Isnard F, Brethon B, Lacroix C, Poirot JL, Bouges C, Derouin F, Tazi A, Ribaud P. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leucocyte count of patients with hematological malignancies. Blood : Bergeron A, Porcher R, Raffoux E, Sulahian A, Ribaud P. Response assessment in invasive aspergillosis. Clin Infect Dis May 4. [Epub ahead of print] Couderc LJ, Blanc FX, Cadranel J. Respiratory medicine and HIV infection: 30 years of shared history. Rev Mal Respir Jun;29(6): Fillatre P, Chevrier S, Revest M, Gacouin A, Jouneau S, Leroy H, Robert-Gangneux F, Minjolle S, Le Tulzo Y, Tattevin P. Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia. Eur J Clin Microbiol Infect Dis Aug 22. [Epub ahead of print] Godet C, Elsendoorn A, Roblot F. Benefit of CT scanning for assessing pulmonary disease in the immunodepressed patient. Diagn Interv Imaging Jun;93(6): Géraldine Salmeron, Raphaël Porcher, Anne Bergeron, Marie Robin, Régis Peffault de Latour, Christèle Ferry, Vanderson Rocha, Anna Petropoulou, Aliénor Xhaard, Claire Lacroix, Annie Sulahian, Gérard Socié, Patricia Ribaud. Persistent Poor Long-Term Prognosis of Allogeneic Haematopoietic Stem Cell Transplant Recipients Surviving Invasive Aspergillosis. Haematologica, 2012; Sep;97(9): HIV-CAUSAL Collaboration. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clin Infect Dis May;54(9):

3 Lanoix JP, Schmit JL, Douadi Y. Bacterial lung sepsis in patients with febrile neutropenia. Curr Opin Pulm Med May;18(3): Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O; French Mycosis Study Group. A global analysis of mucormycosis in France: the RetroZygo Study ( ). Clin Infect Dis Feb;54 Suppl 1:S Levesque E, Hoti E, Azoulay D, Honore I, Guignard B, Vibert E, Ichai P, Antoun F, Saliba F, Samuel D. Pulmonary Complications After Elective Liver Transplantation-Incidence, Risk Factors, and Outcome. Transplantation Sep 15;94(5): Lhuillier E, Brugière O, Veziris N, Danel C, Mourvilliers B, Mal H, Dauriat G, Ruimy R. Relapsing Mycobacterium Genavense Infection as a Cause of Late Death in a Lung Transplant Recipient: Case Report and Review of the Literature. Exp Clin Transplant Jul 4. doi: /ect Pang KA, Godet C, Fekkar A, Scholler J, Nivoix Y, Letscher-Bru V, Massias L, Kauffmann- Lacroix C, Elsendoorn A, Uzunov M, Datry A, Herbrecht R. Breakthrough invasive mould infections in patients treated with caspofungin. J Infect Apr;64(4): Mycobactéries Andréjak C, Nielsen R, Thomsen VO, Duhaut P, Sørensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax Jul 10. [Epub ahead of print] Bergot E, Haustraete E, Malbruny B, Magnier R, Salaün MA, Zalcman G. Observational Study of QuantiFERON -TB Gold In-Tube Assay in Tuberculosis Contacts in a Low Incidence Area. PLoS One. 2012;7(8):e Bernard C, Sougakoff W, Fournier A, Larnaudie S, Antoun F, Robert J, Brossier F, Truffot- Pernot C, Jarlier V, Veziris N. Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris. Int J Tuberc Lung Dis May;16(5): Bussone G, Brossier F, Roudiere L, Bille E, Sekkal N, Charlier C, Gilquin J, Lanternier F, Lecuit M, Lortholary O, Catherinot E. Recurrent Mycobacterium avium infection after seven years of latency in a HIV-infected patient receiving efficient antiretroviral therapy. J Infect Jan 3. [Epub ahead of print] Catherinot E, Roux AL, Vibet MA, Bellis G, Lemonnier L, Le Roux E, Bernède-Bauduin C, Le Bourgeois M, Herrmann JL, Guillemot D, Gaillard JL; for the OMA group.. Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients. Eur Respir J Aug 30. [Epub ahead of print] Catherinot E, Roux AL, Vibet MA, Bellis G, Ravilly S, Lemonnier L, Le Roux E, Bernède- Bauduin C, Le Bourgeois M, Herrmann JL, Guillemot D, Gaillard JL; For the OMA group. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros Jul 31. [Epub ahead of print] Cosson MA, Bertrand JB, Martin C, Veziris N, Picard C, Goulvestre C, Coignard S, Benoit JP, Silvera S, Moro MR, Poyart C, Morand P. Temporal interferon-gamma release response to Mycobacterium kansasii infection in anorexia nervosa. J Med Microbiol Aug 2.

4 Fournier A, Antoun F, Collignon A, Muller G, Rouvier J, Ayache B, Guesnon MS, Larnaudie S. [Screening contacts for latent tuberculosis infection (LTBI) using an interferon test in Paris in 2009]. Rev Mal Respir Jan;29(1): Fraisse P. Diagnostic des infections tuberculeuses latentes (sujets sains, sujets immunodéprimés ou amenés à l être). Rev Mal Respir ; 29 (2) : Grammatico-Guillon L, Lanotte P, Bastides F, Veziris N, Bernard L, Rosset P. Voluminous pseudotumor due to Mycobacterium malmoense. Presse Med Apr 13. [Epub ahead of print] Tattevin P, Che D, Fraisse P, Gatey C, Guichard C, Antoine D, Paty MC, Bouvet E. Factors associated with patient and health care system delay in the diagnosis of tuberculosis in France. Int J Tuberc Lung Dis. 2012;en cours de soumission Meyssonnier V, Veziris N, Bastian S, Texier-Maugein J, Jarlier V, Robert J. Increase in primary drug resistance of Mycobacterium tuberculosis in younger birth cohorts in France. J Infect Feb 1. [Epub ahead of print] Pantel A, Petrella S, Veziris N, Brossier F, Bastian S, Jarlier V, Mayer C, Aubry A. Extending GyrB QRDR definition in Mycobacterium tuberculosis DNA gyrase for assessing FQ resistance in M. tuberculosis. Antimicrob Agents Chemother Jan 30. [Epub ahead of print] N. Valin, C. Chouaïd. La tuberculose en France en 2010 : épidémiologie, clinique et microbiologie. Rev Mal Respir ; 29 (2) : Communautaire Alifano M, Lorut C, Lefebvre A, Khattar L, Damotte D, Huchon G, Regnard JF, Rabbat A. Necrotizing pneumonia in adults: multidisciplinary management. Intensive Care Med Nov;37(11): Charlier-Woerther C, Fenoll C, Bouges-Michel C, Valeyre D, Lortholary O, Masquelet AC. Cryptococcal myositis and sarcoidosis. Med Mal Infect May;41(5): Cuquemelle E, Soulis F, Villers D, Roche-Campo F, Ara Somohano C, Fartoukh M, Kouatchet A, Mourvillier B, Dellamonica J, Picard W, Schmidt M, Boulain T, Brun-Buisson C; A/H1N1 REVA- SRLF Study Group. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med May;37(5): Delcourt VA, Nion N, Bricaire F, Similowski T, Delpech VN. [Planning for an H1N1 influenza pandemic, specific enforcement of a white plan]. Soins Dec;(741):45-7. Guillon A, Montharu J, Cormier B, Vecellio L, Diot P, de Monte M. New insights into the pathophysiology of aspiration pneumonia. Br J Anaesth Apr;106(4): Mayaud C, Fartoukh M, Cadranel J. [When pneumonia does not respond to

5 antibiotic therapy]. Rev Prat Oct;61(8): Mayaud C. [Pneumonia is the leading cause of death of infectious origin]. Rev Prat Oct;61(8): Puisieux F, D'Andrea C, Baconnier P, Bui-Dinh D, Castaings-Pelet S, Crestani B, Desrues B, Ferron C, Franco A, Gaillat J, Guenard H, Housset B, Jeandel C, Jebrak G, Leymarie- Saddles A, Orvoen-Frija E, Piette F, Pinganaud G, Salle JY, Strubel D, Vernejoux JM, de Wazières B, Weil-Engerer S; Intergroupe PneumoGériatrie SPLF SFGG placé sous l égide de la Société de pneumologie de langue française (SPLF) et de la Société française de gériatrie et gérontologie (SFGG). Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly. Rev Mal Respir Oct;28(8):e Salvator H, Devillier P, Rivaud E, Catherinot E, Honderlick P, Couderc LJ. [Obesity, poor prognostic factor in pandemic influenza A (H1N1) 2009: the role of adipokines in the modulation of respiratory defenses]. Rev Pneumol Clin Sep;67(4): Voiriot G, Dury S, Parrot A, Mayaud C, Fartoukh M. Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia. Chest Feb;139(2): Infections/Pathologie pulmonaire chronique Dhote R, Abad S, Valeyre D. [The infectious complications of sarcoidosis]. Presse Med Feb;38(2): Jouneau S, Bonizec M, Belleguic C, Desrues B, Brinchault G, Galaine J, Gangneux JP, Martin-Chouly C. Anti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosis. PLoS One. 2011;6(8):e Laroumagne S, Salinas-Pineda A, Hermant C, Murris M, Gourraud PA, Do C, Segonds C, Didier A, Mazières J. [Incidence and characteristics of bronchial colonisation in patient with lung cancer: a retrospective study of 388 cases]. Rev Mal Respir Mar;28(3): Lejay A, Falcoz PE, Santelmo N, Helms O, Kochetkova E, Jeung M, Kessler R, Massard G. Surgery for aspergilloma: time trend towards improved results? Interact Cardiovasc Thorac Surg Oct;13(4): Miossec C, Morio F, Lepoivre T, Le Pape P, Garcia-Hermoso D, Gay-Andrieu F, Haloun A, Treilhaud M, Leclair F, Miegeville M. Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis. J Clin Microbiol Jul;49(7): Morand PC, Burgel PR, Carlotti A, Desmazes-Dufeu N, Farhi D, Martin C, Kanaan R, Mangialavori L, Palangié E, Dusser D, Poyart C, Hubert D. Mediastinal tuberculosis in an adult patient with cystic fibrosis. J Clin Microbiol Feb;49(2): Nseir S, Ader F, Lubret R, Marquette CH. Pathophysiology of Airway Colonization in Critically Ill COPD Patient. Curr Drug Targets 2011, 12, Olland A, Falcoz PE, Kessler R, Massard G. Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation? Interact Cardiovasc Thorac Surg Dec;13(6):631-4.

6 Raynaud C, Roche N, Chouaid C. Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects. Respir. Res. 2011;12:117. Reddel HK, Jenkins C, Quirce S, Sears MR, Bateman ED, O'Byrne PM, Humbert M, Buhl R, Harrison T, Brusselle GG, Thorén A, Sjöbring U, Peterson S, Ostlund O, Eriksson GS.Effect of different asthma treatments on risk of cold-related exacerbations. Eur Respir J 2011; 38: Roux AL, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, Bellis G, Vibet MA, Le Roux E, Lemonnier L, Gutierrez C, Vincent V, Fauroux B, Rottman M, Guillemot D, Gaillard JL; Jean-Louis Herrmann for the OMA Group. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol Dec;47(12): Tillie-Leblond I, Germaud P, Leroyer C, Tétu L, Girard F, Devouassoux G, Grignet JP, Prudhomme A, Dusser D, Wallaert B. Allergic bronchopulmonary aspergillosis and omalizumab. Allergy Sep;66(9): Valmary S, Dorfmüller P, Montani D, Humbert M, Brousset P, Degano B. Human gammaherpesviruses EBV and HHV-8 are not detected in the lungs of patients with severe pulmonary arterial hypertension. Chest 2011; 139: Vecellio L, Abdelrahim ME, Montharu J, Galle J, Diot P, Dubus JC. Disposable versus reusable jet nebulizers for cystic fibrosis treatment with tobramycin. J Cyst Fibros Mar;10(2): Immunodéprimés Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, Molina JM, Derouin F, Menotti J. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect Oct;17(10): Almodovar S, Knight R, Allshouse AA, Roemer S, Lozupone C, McDonald D, Widmann JJ, Voelkel N, Shelton RJ, Suarez-Martinez EB, Hammer K, Goujard CM, Petrosillo N, Simonneau G, Hsue PY, Humbert M, Flores SC. Human immunodeficiency virus nef signature sequences are associated with pulmonary hypertension. AIDS Res Hum Retroviruses 2011 Nov 9 [Epub ahead of print]. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, Kim C, Lak KK, Hak C, Dim B, Sin CI, Sun S, Guillard B, Sar B, Vong S, Fernandez M, Fox L, Delfraissy JF, Goldfeld AE; CAMELIA (ANRS 1295 CIPRA KH001) Study Team. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med Oct 20;365(16): Belaiche S, Roustit M, Bedouch P, Quetant S, Saint-Raymond C, Pison C. Management of voriconazole hepatotoxicity in a lung transplant patient. Transpl Infect Dis Jun;13(3): Blanchard E, Lortholary O, Boukris-Sitbon K, Desnos-Ollivier M, Dromer F, Guillemot D; French Mycosis Study Group. Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in

7 Candida spp.: a case-control study in Paris, France. Antimicrob Agents Chemother Nov;55(11): Crockett F, Mal H, Amazzough K, Stern M, Rivaud E, Cerf C, Matthieu E, Honderlick P, Scherrer A, Couderc LJ. [H1N1 (2009) influenza A infection in transplant recipient patients: a comparative study versus non-transplanted patients]. Rev Pneumol Clin Sep;67(4): Fily F, Lachkar S, Thiberville L, Favennec L, Caron F. Pneumocystis jirovecii colonization and infection among non HIV-infected patients. Med Mal Infect Oct;41(10): Lanoy E, Spano JP, Bonnet F, Guiguet M, Boué F, Cadranel J, Carcelain G, Couderc LJ, Frange P, Girard PM, Oksenhendler E, Poizot-Martin I, S le C, Agut H, Katlama C, Costagliola D; ONCOVIH study group. The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study. Int J Cancer Jul 15;129(2): Lanoix JP, Andrejak C, Schmit JL. Antiretroviral therapy in intensive care. Med Mal Infect Jul;41(7): Lanoix JP, Pluquet E, Lescure FX, Bentayeb H, Lecuyer E, Boutemy M, Dumont P, Jounieaux V, Schmit JL, Dayen C, Douadi Y. Bacterial infection profiles in lung cancer patients with febrile neutropenia. BMC Infect Dis Jun 27;11:183. Lanoix JP, Douadi Y, Borel A, Andrejak C, El Samad Y, Ducroix JP, Schmit JL. Lymph node tuberculosis treatment: from recommendations to practice. Med Mal Infect Feb;41(2): Machouart M, Garcia-Hermoso D, Rivier A, Hassouni N, Catherinot E, Salmon A, Debourgogne A, Coignard H, Lecuit M, Bougnoux ME, Blanche S, Lortholary O. Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis. J Clin Microbiol Apr;49(4): Martinez S, Sellam V, Marco S, Sanfiorenzo C, Macone F, Marquette CH. Tuberculosis and pneumocystis: An unusual co-infection. Rev Mal Respir. 2011;28: MESSIKA J., PARQUIN F., PUYO P., SAGE E., BONNETTE P., RIVAUD E., CATHERINOT E., COUDERC L.J., CHAPELIER A. Chirurgie pulmonaire chez le malade d'hématologie : pourquoi? pour qui? Rev. Pneumol. Clin ; 67 : Morisse H, Heyman L, Salaün M, Favennec L, Picquenot JM, Bohn P, Thiberville L. In vivo and in situ imaging of experimental invasive pulmonary aspergillosis using fibered confocal fluorescence microscopy. Med Mycol Oct 17. [Epub ahead of print] Phai Pang KA, Godet C, Fekkar A, Scholler J, Nivoix Y, Letscher-Bru V, Massias L, Kauffmann-Lacroix C, Elsendoorn A, Uzunov M, Datry A, Herbrecht R. Breakthrough invasive mould infections in patients treated with caspofungin. J Infect Dec 29. [Epub ahead of print] Toper C, Rivaud E, Daniel C, Cerf C, Parquin F, Catherinot E, Honderlick P, Escande MC, Dreyfus JF, Stern M, Couderc LJ. [Pneumocystis jirovecii pneumonia in non-hiv infected patients: a study of 41 cases]. Rev Pneumol Clin Sep;67(4):191-8.

8 TCHERAKIAN C., RIVAUD E., CATHERINOT E., ZUCMAN D., METIVIER A.C., COUDERC L.J. Hypertension artérielle pulmonaire liée à l'infection VIH : de la pression artérielle pulmonaire à l'interluekine-6. Rev. Pneumol. Clin ; 67 : Touinssi M, Reynaud-Gaubert M, Gomez C, Thomas P, Dussol B, Berland Y, Basire A, Picard C, Cantaloube JF, de Micco P, Biagini P. Parvovirus 4 in French in-patients: a study of hemodialysis and lung transplant cohorts. J Med Virol Apr;83(4): Mycobactéries Agossou M, Gargouri I, Holveck A, Dimitriu CP, Fraisse P, Quoix E. [A conus medullaris tuberculoma: a case report and literature review]. Rev Mal Respir May;28(5): Andréjak C, Lescure FX, Schmit JL, Jounieaux V. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract]. Rev Mal Respir Dec;28(10): Antoun F, Véziris N. [Managing multidrug-resistant tuberculosis]. Rev Mal Respir Oct;28(8): Bachmeyer C, Fouqueray B, Fabien N, Cadranel J, Haymann JP. Autoimmune hypoparathyroidism associated with pulmonary tuberculosis. QJM May;104(5): Bastian S, Veziris N, Roux AL, Brossier F, Gaillard JL, Jarlier V, Cambau E. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother Feb;55(2): Blanc FX, Janssens JP, Underner M. [Tuberculosis and non-tuberculous mycobacteria: Respiratory medicine on pole position]. Rev Mal Respir Apr;28(4): Bouakaze C, Keyser C, Gonzalez A, Sougakoff W, Veziris N, Dabernat H, Jaulhac B, Ludes B. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based single nucleotide polymorphism genotyping assay using iplex gold technology for identification of Mycobacterium tuberculosis complex species and lineages. J Clin Microbiol Sep;49(9): Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother Jan;55(1): Chartier L, Leng C, Sire JM, Le Minor O, Saman M, Bercion R, Rahalison L, Fontanet A, Germany Y, L'her P, Mayaud C, Vray M. Factors associated with negative direct sputum examination in Asian and African HIV-infected patients with tuberculosis (ANRS 1260). PLoS One. 2011;6(6):e Lanoix JP, Douadi Y, Borel A, Andrejak C, El Samad Y, Ducroix JP, Schmit JL. [Lymph node tuberculosis treatment: from recommendations to practice]. Med Mal Infect Feb;41(2): Lino A, Lalande V, Guetta A, Lebeau B, Heron E, Chouaid C. Diagnostic des uveites tuberculeuses : implications cliniques des tests interferons. Rev Mal Respir 2011;28:

9 Prevotat A, Bonne S, Veziris N, Senneville E, Yazdanpanah Y, Legout L. Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient]. Med Mal Infect Aug;41(8): Rammaert B, Couderc LJ, Rivaud E, Honderlick P, Zucman D, Mamzer MF, Cahen P, Bille E, Lecuit M, Lortholary O, Catherinot E. Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency. BMC Infect Dis Nov 5;11:311. Roux AL, Ray A, Pawlik A, Medjahed H, Etienne G, Rottman M, Catherinot E, Coppée JY, Chaoui K, Monsarrat B, Toubert A, Daffé M, Puzo G, Gaillard JL, Brosch R, Dulphy N, Nigou J, Herrmann JL. Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent mycobacterial variants. Cell Microbiol May;13(5): Schneider P, Monsel G, Veziris N, Roujeau JC, Bricaire F, Caumes E. Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patients. Dermatol Online J Mar 15;17(3):8. Schubel K, Bassinet L, Monnet I, Jabot L, Atassi K, Honoré I, Maître B, Housset B, Mangiapan G. [Pleuropneumonia due to Mycobacterium chelonae]. Rev Mal Respir Mar;28(3): Tillie-Leblond I, Grenouillet F, Reboux G, Roussel S, Chouraki B, Lorthois C, Dalphin JC, Wallaert B, Millon L. Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria. Eur Respir J Mar;37(3): Tochon M, Bosdure E, Salles M, Beloncle C, Chadelat K, Dagorne M, Gaudelus J, Losi S, Renoux MC, Veziris N, Dubus JC. Management of young children in contact with an adult with drug-resistant tuberculosis, France, Int J Tuberc Lung Dis Mar;15(3): Truffot-Pernot C, Veziris N. [Bacteriological tests for tuberculosis]. Rev Mal Respir Oct;28(8): Veziris N, Ibrahim M, Lounis N, Andries K, Jarlier V. Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosis. PLoS One Mar 3;6(3):e Veziris N, Truffot C, Mainardi JL, Jarlier V. Activity of carbapenems combined with clavulanate against murine tuberculosis. Antimicrob Agents Chemother Jun;55(6): Nosocomial Befort P, Corne P, Riviere B, Bourdin A, Jonquet O. [Ecthyma gangrenosum and Pseudomonas aeruginosa septicemia in intensive care unit]. Ann Fr Anesth Reanim Jan;30(1):80-2. Martin C, Thévenot G, Danel S, Chapron J, Tazi A, Macey J, Dusser DJ, Fajac I, Burgel PR. Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. Eur Respir J Oct;38(4): Rares

10 Lecsö-Bornet M, Brossier F, Lerat I, Gabarre J, Morelot-Panzini C, Similowski T, Jarlier V. Legionella wadsworthii pneumonia: gram stain usefulness. Med Mal Infect Dec;41(12): Locatelli Sanchez M, Mornex JF, Philit F, Chumbi Floresa W. [Pulmonary nodules upon return from Costa Rica]. Rev Mal Respir Sep;28(7): Paganin F, Bourdin A, Borgherini G, Dalban C, Poubeau P, Tixier F, Gouix A, Noel JB, Cotte L, Arvin-Berod C. Pulmonary manifestations of leptospirosis. Rev Mal Respir Nov;28(9):e Rammaert B, Beauté J, Borand L, Hem S, Buchy P, Goyet S, Overtoom R, Angebault C, Te V, Try PL, Mayaud C, Vong S, Guillard B. Pulmonary melioidosis in Cambodia: a prospective study. BMC Infect Dis May 14;11:126. Rivière F, Gille T, Le Tinier JY, Gharbi N, Khalil A, Wislez M, Cadranel J. Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion. Scand J Infect Dis Feb;43(2): Communautaire Djibré M, Berkane N, Salengro A, Ferrand E, Denis M, Chalumeau-Lemoine L, Parrot A, Mayaud C, Fartoukh M. Non-invasive management of acute respiratory distress syndrome related to Influenza A (H1N1) virus pneumonia in a pregnant woman. Intensive Care Med Feb;36(2): Martinez JS, Le Falher G, Corne P, Bourdin A, Lequellec A, Delabre JP, Makinson A, Hansel S, Reynes J, Le Moing V. [Adherence to antibiotherapy guidelines for acute communityacquired pneumonia in adults, in a teaching hospital]. Med Mal Infect Aug;40(8): Immunodéprimés Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, Vincent F, Gruson D, Bruneel F, Epinette-Branche G, Lafabrie A, Hamidfar Roy R, Cracco C, Renard B, Tonnelier JM, Blot F, Chevret S, Schlemmer B. Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory Failure: Randomized Controlled Trial. Am J Respir Crit Care Med (9) : Bergeron A, Belle A, Sulahian A, Lacroix C, Chevret S, Raffoux E, Arnulf B, Socié G, Ribaud P, Tazi A. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest Feb;137(2): Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O. Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am Mar;24(1):

11 Camous L, Lemiale V, Canet E, Max A, Schnell D, Le Goff J, Rabbat A, Schlemmer B, Azoulay E. Clinical features of H1N infection in critically ill immunocompromised patients. Crit Care. 2010;14(2):139. Degano B, Guillaume M, Savale L, Montani D, Jaïs X, Yaici A, Le Pavec J, Humbert M, Simonneau G, Sitbon O. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS 2010; 24: Epaulard O, Saint-Raymond C, Villier C, Charles J, Roch N, Beani JC, Leccia MT. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients. Clin Microbiol Infect Sep;16(9): Hantz S, Garnier-Geoffroy F, Mazeron MC, Garrigue I, Merville P, Mengelle C, Rostaing L, Saint Marcoux F, Essig M, Rerolle JP, Cotin S, Germi R, Pillet S, Lebranchu Y, Turlure P, Alain S; French CMV Resistance Survey Study Group. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study. J Antimicrob Chemother Dec;65(12): Hantz S, Garnier-Geoffroy F, Mazeron MC, Garrigue I, Merville P, Mengelle C, Rostaing L, Saint Marcoux F, Essig M, Rerolle JP, Cotin S, Germi R, Pillet S, Lebranchu Y, Turlure P, Alain S; French CMV Resistance Survey Study Group. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study. J Antimicrob Chemother Dec;65(12): Kousignian I, Launay O, Mayaud C, Rabaud C, Costagliola D, Abgrall S; FHDH-ANRS CO4. Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy? J Antimicrob Chemother Jan;65(1): Lebeaux D, Lanternier F, Degand N, Catherinot E, Podglajen I, Rubio MT, Suarez F, Lecuit M, Mainardi JL, Lortholary O. Nocardia pseudobrasiliensis as an emerging cause of opportunistic infection after allogeneic hematopoietic stem cell transplantation. J Clin Microbiol Feb;48(2): Loussert C, Schmitt C, Prevost MC, Balloy V, Fadel E, Philippe B, Kauffmann-Lacroix C, Latgé JP, Beauvais A. In vivo biofilm composition of Aspergillus fumigatus. Cell Microbiol Mar;12(3): Morio F, Horeau-Langlard D, Gay-Andrieu F, Talarmin JP, Haloun A, Treilhaud M, Despins P, Jossic F, Nourry L, Danner-Boucher I, Pattier S, Bouchara JP, Le Pape P, Miegeville M. Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis. J Clin Microbiol May;48(5): Philippe B, Grenet D, Honderlick P, Longchampt E, Dupont B, Picard C, Stern M. Severe Aspergillus endocarditis in a lung transplant recipient with a five-year survival. Transpl Infect Dis Jun;12(3): Régnier-Rosencher E, Barrou B, Marcelin AG, Jacobzone-Leveque C, Cadranel J, Leblond V, Francés C. [Primary effusion lymphoma in two kidney transplant recipients]. Ann Dermatol Venereol Apr;137(4): Sire JM, Sow PS, Chartier L, Ndiaye B, Ndaye M, Sarr FD, Vray M, Boye CS, M'boup S, L'her P, Debonne JM, Mayaud C, Diop B. [Aetiology of AFB negative pneumonias in hospitalized HIV patients in Dakar]. Rev Mal Respir Nov;27(9):

12 Infections/Pathologie pulmonaire chronique Beucher J, Belleguic C, Brinchault G, Deneuville E, Donnio PY, Roussey M. [Nocardia farcinica infection in a patient with cystic fibrosis]. Rev Mal Respir. 2010;27(1):76-9. Bittar F, Cassagne C, Bosdure E, Stremler N, Dubus JC, Sarles J, Reynaud-Gaubert M, Raoult D, Rolain JM. Outbreak of Corynebacterium pseudodiphtheriticum infection in cystic fibrosis patients, France. Emerg Infect Dis Aug;16(8): Blanchard E, Raherison C. Asthma and Mycoplasma pneumoniae]. Rev Mal Respir Oct;27(8): Gangneux JP, Camus C, Philippe B. Epidemiology of invasive aspergillosis and risk factors in non neutropaenic patients. Rev Mal Respir Oct;27(8):e Germaud P, Pipet A. [Allergic bronchopulmonary aspergillosis: new therapeutic options]. Rev Mal Respir Sep;27(7): Montani D, Zendah I, Achouh L, Dorfmuller P, Mercier O, Garcia G, Humbert M. Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis. Eur Respir Rev 2010; 19: Paugam A, Baixench MT, Demazes-Dufeu N, Burgel PR, Sauter E, Kanaan R, Dusser D, Dupouy-Camet J, Hubert D. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol Nov;48 Suppl 1:S32-6. Prévotat A, Leroy S, Perez T, Wallet F, Wallaert B. [Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis]. Rev Mal Respir May;27(5): Roche N, Rabbat A, Zureik M, Huchon G. Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome. Curr Opin Pulm Med Mar;16(2): Roche N, Gaillat J, Garre M, Meunier J-P, Lemaire N, Bendjenana H. Acute respiratory illness as a trigger for detecting chronic bronchitis in adults at risk of COPD: a primary care survey. Prim Care Respir J. 2010;19(4): Van Grunderbeeck N, Conseil V, Leroy S, Wallaert B, Delhaes L. [The fungal risk in cystic fibrosis: a pilot study]. Ann Biol Clin (Paris) Mar-Apr;68(2): Mycobactéries Abalain ML, Petsaris O, Héry-Arnaud G, Marcorelles P, Couturaud F, Dobrzynski M, Payan C, Gutierrez C. Fatal congenital tuberculosis due to a Beijing strain in a premature neonate. J Med Microbiol Jun;59(Pt 6): Andréjak C, Thomsen VØ, Johansen IS, Riis A, Benfield TL, Duhaut P, Sørensen HT, Lescure FX, Thomsen RW. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med Mar 1;181(5): Bastian S, Brossier F, Wichlacz C, Jarlier V, Veziris N. Daptomycin is not active against rapidly growing mycobacteria. J Med Microbiol Jan;59(Pt 1):135-6.

13 Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrugresistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol May;48(5): Bouakaze C, Keyser C, de Martino SJ, Sougakoff W, Veziris N, Dabernat H, Ludes B. Identification and genotyping of Mycobacterium tuberculosis complex species by use of a SNaPshot Minisequencing-based assay. J Clin Microbiol May;48(5): Ichai P, Saliba F, Antoun F, Azoulay D, Sebagh M, Antonini TM, Escaut L, Delvart V, Castaing D, Samuel D. Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation. Liver Transpl Oct;16(10): Heym B, Beauchet A, Ngo MT, Gaillard JL, Chinet Th. Sputum induction vs gastric washing for the diagnosis of pulmonary mycobacterial disease. Eur Respir J 2010; 36: Lotz A, Ferroni A, Beretti JL, Dauphin B, Carbonnelle E, Guet-Revillet H, Veziris N, Heym B, Jarlier V, Gaillard JL, Pierre-Audigier C, Frapy E, Berche P, Nassif X, Bille E. Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol Dec;48(12): Lounis N, Guillemont J, Veziris N, Koul A, Jarlier V, Andries K. [R (TMC207): a new antibiotic for the treatment of tuberculosis]. Med Mal Infect Jul;40(7): Migueres B, Carbonne A, Abiteboul D, Poirier C, Bouvet E, Astagneau P. [Tuberculosis among healthcare workers in Northern France ( ): descriptive analysis of notified cases and contact tracing]. Med Mal Infect Sep;40(9): Poissy J, Aubry A, Fernandez C, Lott MC, Chauffour A, Jarlier V, Farinotti R, Veziris N. Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model. Antimicrob Agents Chemother Nov;54(11): Sire JM, Sow PS, Chartier L, Ndiaye B, Ndaye M, Sarr FD, Vray M, Boye CS, M'boup S, L'her P, Debonne JM, Mayaud C, Diop B. [Aetiology of AFB negative pneumonias in hospitalized HIV patients in Dakar]. Rev Mal Respir Nov;27(9): Valin N, Hejblum G, Borget I, Mallet HP, Antoun F, Che D, Chouaid C. Factors associated with excessively lengthy treatment of tuberculosis in the eastern Paris region of France in BMC Public Health 2010;10:495. Veziris N, Robert J. [Anti-tuberculosis drug resistance and therapeutic dead end]. Med Sci (Paris) Nov;26(11): Nosocomial Lu Q, Girardi C, Mao Zhang, Bouhemad B, Louchahi K, Petitjean O, Wallet F, Becquemin MH, Le Naour G, Marquette CH, Rouby JJ. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intens Care Med 2010 Apr 16. [Epub ahead of print]

14 Nseir S, Makris D, Mathieu D, Durocher A, Marquette CH. Intensive care unit-acquired infection as a side effect of sedation. Crit Care 2010 Mar 15;14(2):R30. [Epub ahead of print] Rares Dos Santos Fernandes CJ, Jardim CVP, Hovnanian A, Hoette S, Dias BA, Souza S, Humbert M, Souza R. Survival in schistosomiasis-associated pulmonary arterial hypertension. J Am Coll Cardiol 2010; 56: Guilleminault L, Holstein A, Azzouz M, Favelle O, Lanotte P, Diot P. [Tropical pneumonia: pulmonary melioidosis]. Rev Med Interne Jul;31(7):e4-7. Vaccins Wattrelot P, Brion JP, Labarère J, Billette de Villemeur A, Girard-Blanc MF, Stahl JP, Brambilla C. [Vaccination practices following the end of compulsory BCG vaccination. A cross-sectional survey of general practitioners and pediatricians]. Arch Pediatr Feb;17(2): Autres Imperiale A, Federici L, Lefebvre N, Braun JJ, Pfumio F, Kessler R, Hansmann Y, Andres E, Constantinesco A. F-18 FDG PET/CT as a valuable imaging tool for assessing treatment efficacy in inflammatory and infectious diseases. Clin Nucl Med Feb;35(2): Traclet J, Cottin V, Duvert B, Thivolet-Bejui F, Berger F, Coiffier B, Cordier JF. [Epstein-Barr virus associated pulmonary lymphoma in Sjögren's syndrome]. Rev Mal Respir May;27(5): Communautaire Balcan D, Colizza V, Singer AC, Chouaid C, Hu H, Gonçalves B, Bajardi P, Poletto C, Ramasco JJ, Perra N, Tizzoni M, Paolotti D, Van den Broeck W, Valleron A, Vespignani A. Modeling the critical care demand and antibiotics resources needed during the Fall 2009 wave of influenza A(H1N1) pandemic. PLoS Curr 2009;1:RRN1133. Baudrand H, Mbatchou Ngahane BH, Marcu M, Freymond N, Pacheco Y, Devouassoux G. [Lung abscess due to community acquired Klebsiella pneumonia]. Rev Mal Respir Sep;26(7): Dharmage SC, Erbas B, Jarvis D, Wjst M, Raherison C, Norbäck D, Heinrich J, Sunyer J, Svanes C. Do childhood respiratory infections continue to influence adult respiratory morbidity? Eur Respir J Feb;33(2): Housset B. [The H1N1 pandemic: where are we?]. Rev Mal Respir Sep;26(7): Immunodéprimés

15 Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-hiv immunocompromised patients with pulmonary infiltrates. Chest Mar;135(3): Brugière O, Forget E, Biondi G, Métivier AC, Mal H, Dauriat G, Faussart A, Dupont B, Lortholary O, Dromer F. Coccidioidomycosis in a lung transplant recipient acquired from the donor graft in France. Transplantation Dec 15;88(11): Chandenier J, Bernard S, Montharu J, Bailly E, Fetissof F, de Monte M, Desoubeaux G, Diot P, Richard-Lenoble D. The utility of a nebulised intra-tracheal rat model of invasive pulmonary aspergillosis. Mycoses May;52(3): Degano B, Yaïci A, Le Pavec J, Savale L, Jaïs X, Camara B, Humbert M, Simonneau G, Sitbon O. Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension. Eur Respir J 2009; 33:92-8. DUCHET-NIEDZIOLKA P., LAUNAY O., COUTSINOS Z., AJANA F., ARLET P., BARROU B., BEYTOUT J., BOUCHAUD O., BROUQUI P., BUZYN A., CHIDIAC C., COUDERC L.J., DEBORD T., DELLAMONICA P., DHOTE R., DUBOUST A., DURRBACH A., FAIN O., FIOR R., GODEAU B., GOUJARD C., HACHULLA E., MARCHOU B., MARIETTE X., MAY T., MEYER O., MILPIED N.n MORLAT P.,POUCHOT J., TATTEVIN P., VIARD J.P., LORTHOLARLY O., HANSLIK T ; GEVACCIM. Vaccination in adults with auto-immune disease and/or drug related immune deficiency : results of the GEVACCIM Delphi survey. Vaccine ; 37 : El Karoui K, Guillet C, Sekkal N, Lanternier F, Méchaï F, Hue K, Hiesse C, Mamzer Bruneel MF, Catherinot E, Viard JP, Mainardi JL, Lecuit M, Ferroni A, Lortholary O. Synergistic effect of carbapenem-teicoplanin combination during severe Rhodococcus equi pneumonia in a kidney transplant recipient. Transpl Infect Dis Aug;11(4): Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D; Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol Dec;10(12): Guilleminault L, Espanel C, Marcq M, Azzouz M, Diot E, Binet C, Diot P. [Lung abscess secondary to neutropenic myelodysplasia treated with G-CSF]. Rev Mal Respir Jan;26(1):87-9. Minet C, Bonadona A, Tabah A, Karkas A, Mescam L, Schwebel C, Hamidfar R, Pison C, Saint-Raymond C, Faure O, Salameire D, Timsit JF. [Non-fatal disseminated mucormycosis in a solid organ transplant]. Rev Mal Respir Nov;26(9): Mourez T, Bergeron A, Ribaud P, Scieux C, de Latour RP, Tazi A, Socié G, Simon F, LeGoff J. Polyomaviruses KI and WU in immunocompromised patients with respiratory disease. Emerg Infect Dis Jan;15(1): Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Muñoz P, Patel R, Fortun J, Martin-Davila P, Philippe B, Philit F, Tabah A, Terzi N, Chatelet V, Kusne S, Clark N, Blumberg E, Julia MB, Humar A, Houston S,

16 Lass-Flörl C, Johnson L, Dubberke ER, Barron MA, Lortholary O. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis Sep 15;200(6): Sun HY, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Muñoz P, Patel R, Fortun J, Martin-Davila P, Philippe B, Philit F, Tabah A, Terzi N, Chatelet V, Kusne S, Clark N, Blumberg E, Julia MB, Humar A, Houston S, Lass-Florl C, Johnson L, Dubberke ER, Barron MA, Lortholary O, Singh N; Zygomycosis Transplant Study Group. Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant Sep;9(9): Infections/Pathologie pulmonaire chronique Bastonero S, Le Priol Y, Armand M, Bernard CS, Reynaud-Gaubert M, Olive D, Parzy D, de Bentzmann S, Capo C, Mege JL. New microbicidal functions of tracheal glands: defective anti-infectious response to Pseudomonas aeruginosa in cystic fibrosis. PLoS One. 2009;4(4):e5357. Hubert D, Leroy S, Nove-Josserand R, Murris-Espin M, Mely L, Dominique S, Delaisi B, Kho P, Kovarik JM. Pharmacokinetics and safety of tobramycin administered by the PARI eflow rapid nebulizer in cystic fibrosis. J Cyst Fibros Sep;8(5): Hubert D, Le Roux E, Lavrut T, Wallaert B, Scheid P, Manach D, Grenet D, Sermet- Gaudelus I, Ramel S, Cracowski C, Sardet A, Wizla N, Deneuville E, Garraffo R. Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis. Antimicrob Agents Chemother Sep;53(9): Rolain JM, François P, Hernandez D, Bittar F, Richet H, Fournous G, Mattenberger Y, Bosdure E, Stremler N, Dubus JC, Sarles J, Reynaud-Gaubert M, Boniface S, Schrenzel J, Raoult D. Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage. Biol Direct Jan 13;4:1. Roux AL, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, Bellis G, Vibet MA, Le Roux E, Lemonnier L, Gutierrez C, Vincent V, Fauroux B, Rottman M, Guillemot D, Gaillard JL; Jean-Louis Herrmann for the OMA Group. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol Dec;47(12): Mycobactéries Andréjak C, Lescure FX, Pukenyte E, Douadi Y, Yazdanpanah Y, Laurans G, Schmit JL, Jounieaux V; Xenopi Group. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax Apr;64(4): Bourgarit A, Mallet HP, Keshtmand H, De Castro N, Rambeloarisoa J, Fain O, Antoun F, Picard C, Rocher G, Che D, Farge D; pour TB-info. [Follow-up with the assistance of TB-info software of 208 tuberculosis patients who were treated in 2004]. Rev Med Interne Oct;30(10):841-6.

17 Brossier F, Veziris N, Jarlier V, Sougakoff W. Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid. Int J Tuberc Lung Dis Feb;13(2): Catherinot E, Roux AL, Macheras E, Hubert D, Matmar M, Dannhoffer L, Chinet T, Morand P, Poyart C, Heym B, Rottman M, Gaillard JL, Herrmann JL. Acute respiratory failure involving an R variant of Mycobacterium abscessus. J Clin Microbiol Jan;47(1): Che D, Lefebvre N, Antoun F, Fraisse P, Depinoy M, Antoine D, Farge D, Paty MC. [Tuberculosis in France: new challenges for practitioners]. Rev Med Interne Feb;30(2): Fraisse P. [Pulmonary tuberculosis testing and prevention of tuberculosis in patients taking anti-tnf medications]. Rev Mal Respir Apr;26(4): Ibrahim M, Truffot-Pernot C, Andries K, Jarlier V, Veziris N. Sterilizing activity of R (TMC207)-containing regimens in the murine model of tuberculosis. Am J Respir Crit Care Med Sep 15;180(6): Regnier S, Ouagari Z, Perez ZL, Veziris N, Bricaire F, Caumes E. Cutaneous miliary resistant tuberculosis in a patient infected with human immunodeficiency virus: case report and literature review. Clin Exp Dermatol Dec;34(8):e690-2 Tripodi D, Brunet-Courtois B, Nael V, Audrain M, Chailleux E, Germaud P, Naudin F, Muller JY, Bourrut-Lacouture M, Durand-Perdriel MH, Gordeeff C, Guillaumin G, Houdebine M, Raffi F, Boutoille D, Biron C, Potel G, Roedlich C, Geraut C, Schablon A, Nienhaus A. Evaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers. J Occup Med Toxicol Nov 30;4:30. Valin N, Hejblum G, Borget I, Mallet HP, Antoun F, Che D, Chouaid C.Management and treatment outcomes of tuberculous patients, eastern Paris, France, Int J Tuberc Lung Dis 2009;13: Veziris N, Ibrahim M, Lounis N, Chauffour A, Truffot-Pernot C, Andries K, Jarlier V. A onceweekly R containing regimen exceeds activity of the standard daily regimen in murine tuberculosis. Am J Respir Crit Care Med Jan 1;179(1):75-9. Nosocomial Nseir S, Ader F, Marquette CH. Nosocomial tracheobronchitis. Curr Opin Infect Dis.2009;22: Fartoukh M, Ricard JD. [Management of nosocomial pneumonia]. Rev Mal Respir Apr;26(4): Ferrari F, Lu Q, Girardi C, Petitjean O, Marquette CH, Wallet F, Rouby JJ; the Experimental ICU Study Group. Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa. Intens Care Med Oct;35(10): Herer B, Fuhrman C, Gazevic Z, Cabrit R, Chouaïd C. Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures. Clin Microbiol Infect 2009;15: Epub 2009 Jan 10.

18 Nseir S, Ader F, Marquette CH. Nosocomial tracheobronchitis Curr Opin Infect Dis 2009;22: Torres A, Ewig S, Lode H, Carlet J; European HAP working group. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intens Care Med. 2009;35:9-29 Rares Lapa M, Dias B, Jardim C, Fernandes CJC, Dourado PMM, Figueiredo M, Farias A, Tsuitsui J, Terra-Filho M, Humbert M, Souza R. Cardio-pulmonary manifestations of hepatosplenic schistosomiasis. Circulation 2009; 119: Communautaire BOSSI P. COUDERC L.J. Management before suspicion of sporadic cases of avian influenza. Rev. Mal. Respir ; 25 : Brulé N, Jaffré S, Chollet S, Germaud P, Chailleux E. [Necrotizing pneumonia due to Staphylococcus aureus producing Panton-Valentine toxin]. Rev Mal Respir Sep;25(7): Carré P, Chouaïd C. Epidemie aviaire. Rev Mal Respir. 2008;25: Guery B, Guidet B, Beloucif S, Floret D, Legall C, Montravers P, Chouaid C, Jarreau PH, Régnier B. Arch Pediatr. Organisation des unités de soins intensifs en période épidemique. 2008;15: Guinard S, Huchot E, Couturaud F, Quiot JJ, L'hévéder G, Mialon P, de Saint Martin L, Le Gal G, Leroyer C. [A bilateral diaphragmatic paralysis due to Parsonage and Turner syndrome--its evolution over eight years]. Rev Pneumol Clin Jun;64(3): Housset B. [The national prevention plan and the 'influenza pandemic' campaign]. Rev Mal Respir Apr;25(4): Housset B. [The influenza epidemic plan, do you know about it?]. Rev Mal Respir Feb;25(2): Morawiec E, Cavestri B, Bervar JF, Tillie I, Wallaert B. [An unusual pneumonia]. Rev Mal Respir May;25(5): Vinurel H, Karkowski L, Freymond N, Pacheco Y, Rousset H, Devouassoux G, Sailler L. [Lung infections and warts in a 36-year-old man]. Rev Med Interne Nov;29(11): Immunodéprimés

19 Adler D, Chenivesse C, Similowski T, Soccal PM. [Pneumocystis pneumonia in patients with immunosuppression other than HIV infection]. Rev Med Suisse Nov 19;4(180):2525-6, Azoulay E, Mokart D, Rabbat A, Pene F, Kouatchet A, Bruneel F, Vincent F, Hamidfar R, Moreau D, Mohammedi I, Epinette G, Beduneau G, Castelain V, de Lassence A, Gruson D, Lemiale V, Renard B, Chevret S, Schlemmer B.Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med Jan; 36(1): Bittar F, Reynaud-Gaubert M, Thomas P, Boniface S, Raoult D, Rolain JM. Acetobacter indonesiensis pneumonia after lung transplant. Emerg Infect Dis Jun;14(6): Boussaud V, Guillemain R, Grenet D, Coley N, Souilamas R, Bonnette P, Stern M. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax Aug;63(8): De Prost N, Lavolé A, Taillade L, Wislez M, Cadranel J. Gefitinib-associated Propionibacterium acnes pleural empyema. J Thorac Oncol May;3(5): D'Journo XB, Michelet P, Papazian L, Reynaud-Gaubert M, Doddoli C, Giudicelli R, Fuentes PA, Thomas PA. Airway colonisation and postoperative pulmonary complications after neoadjuvant therapy for oesophageal cancer. Eur J Cardiothorac Surg Mar;33(3): Humbert M. Mediators involved in HIV-related pulmonary arterial hypertension. AIDS 2008; 22 Suppl 3:S41-7. Le Minor O, Germani Y, Chartier L, Lan NH, Lan NT, Duc NH, Laureillard D, Fontanet A, Sar B, Saman M, Chan S, L'Her P, Mayaud C, Vray M. Predictors of pneumocystosis or tuberculosis in HIV-infected Asian patients with AFB smear-negative sputum pneumonia. J Acquir Immune Defic Syndr Aug 15;48(5): Levy PY, Habib G, Reynaud-Gaubert M, Raoult D, Rolain JM. Pericardial effusion due to Cryptococcus neoformans in a patient with cystic fibrosis following lung transplantation. Int J Infect Dis Jul;12(4):452. OKSENHENDLER E., GERARD L., FIESCHI C., MALPHETTES M., MOUILLOT G., JAUSSAUD R., VIALLARD J.F., GARDEMBAS M., GALICIER L., SCHLEINITZ N., SUAREZ F., SOULAS-SPRAUEL P., HACHULLA E., JACCARD A., GARDEUR A., THEODOROU I., RABIAN C., DEBREP. DEFI Study Group. Infections in 252 patients with common variable immunodeficiency. Clin. Infect. Dis ; 46 : Rabbat A, Chaoui D, Lefebvre A, Roche N, Legrand O, Lorut C, Rio B, Marie JP, Huchon G. Is BAL useful in patients with acute myeloid leukemia admitted in ICU for severe respiratory complications? Leukemia. 2008; 22(7): Vray M, Germani Y, Chan S, Duc NH, Sar B, Sarr FD, Bercion R, Rahalison L, Maynard M, L'Her P, Chartier L, Mayaud C. Clinical features and etiology of pneumonia in acid-fast bacillus sputum smear-negative HIV-infected patients hospitalized in Asia and Africa. AIDS Jul 11;22(11): Infections/Pathologie pulmonaire chronique

20 Bittar F, Richet H, Dubus JC, Reynaud-Gaubert M, Stremler N, Sarles J, Raoult D, Rolain JM. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS One Aug 6;3(8):e2908. Bittar F, Leydier A, Bosdure E, Toro A, Reynaud-Gaubert M, Boniface S, Stremler N, Dubus JC, Sarles J, Raoult D, Rolain JM. Inquilinus limosus and cystic fibrosis. Emerg Infect Dis Jun;14(6): Gangneux JP, Camus C, Philippe B. [Epidemiology of and risk factors for invasive aspergillosis in nonneutropenic patients]. Rev Mal Respir Feb;25(2): Murris-Espin M, Aubert M, Bosdure E, Dubus JC. Influenza vaccination coverage in patients with cystic fibrosis followed at 12 care centers in the Greater South Region of France for the season 2005/2006. Vaccine Oct 16;26(44): Termoz A, Touzet S, Bourdy S, Decullier E, Bouveret L, Colin C, Nove-Josserand R, Reix P, Cracowski C, Pin I, Bellon G, Durieu I. Effectiveness of home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory infections. Pediatr Pulmonol Sep;43(9): Vinurel H, Freymond N, Pacheco Y, Devouassoux G. [The Whim syndrome: a rare cause of diffuse bronchiectasis. Immune defect of CXCR4 and chronic bronchial suppuration]. Rev Mal Respir May;25(5): Mycobactéries Aissa K, Madhi F, Ronsin N, Delarocque F, Lecuyer A, Decludt B, Remus N, Abel L, Poirier C, Delacourt C; CG94 Study Group. Evaluation of a model for efficient screening of tuberculosis contact subjects. Am J Respir Crit Care Med May 1;177(9): Bergeron A, Herrmann JL. Screening for tuberculosis before TNFalpha antagonist initiation: are current methods good enough? Joint Bone Spine Mar;75(2): Khuê PM, Mallet A, Veziris N, Jarlier V, Robert J; Azay-Mycobacteria Study Group. Evaluation of data quality in a laboratory-based surveillance of M. tuberculosis drug resistance and impact on the prevalence of resistance: France, Epidemiol Infect Sep;136(9): Lachkar S, Casteigt J, Vasseur R, Creuze N, Thiberville L. [Pulmonary and renal tuberculosis with cerebral tuberculoma mimicking metastatic lung cancer]. Rev Mal Respir Jan;25(1):97-9. Lavollay M, Arthur M, Fourgeaud M, Dubost L, Marie A, Veziris N, Blanot D, Gutmann L, Mainardi JL. The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation. J Bacteriol Jun;190(12): Prendki V, Germaud P, Bemer P, Masseau A, Hamidou M. [Non tuberculous mycobacterial infections]. Rev Med Interne May;29(5): Régnier S, Martinez V, Veziris N, Bonvallot T, Meningaud JP, Caumes E. [Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases]. Ann Dermatol Venereol Aug-Sep;135(8-9): Robert J, Veziris N; réseau Azay-Mycobactérie et le Conseil Scientifique de l'onerba. [Resistance to antituberculosis drug in France; data provided by the Azay-Mycobacteria network and the National Reference Center on Mycobacteria]. Med Mal Infect Jun;38 Suppl 2:S Rares

CIBMTR Infection Data and the New Infection Inserts.

CIBMTR Infection Data and the New Infection Inserts. CIBMTR Infection Data and the New Infection Inserts. Marcie Tomblyn, MD, MS Scientific Director, CIBMTR Infection and Immune Reconstitution Working Committee Overview Indication for expanded data collection

More information

Research priorities in medical mycology

Research priorities in medical mycology Research priorities in medical mycology David W. Denning National Aspergillosis Centre University Hospital of South Manchester The University of Manchester Agenda How many patients are there with serious

More information

Surveillance cultures PRO. Kurt Espersen ICU 4131 Rigshospitalet Copenhagen

Surveillance cultures PRO. Kurt Espersen ICU 4131 Rigshospitalet Copenhagen Kurt Espersen ICU 4131 Rigshospitalet Copenhagen Difficult to Diagnose Systemic Candidal Infection Immunsuppression in critically ill patients Frequent manifestation of fungus in ICU Fungi were isolated

More information

Solid Organ Transplantation

Solid Organ Transplantation Solid Organ Transplantation Infection Prevention And Control Transplant Atlantic 2011 October 13/2011 Kathy Hart Introduction In the past several years, the drugs that we use, the surgeries themselves,

More information

Recurrent or Persistent Pneumonia

Recurrent or Persistent Pneumonia Recurrent or Persistent Pneumonia Lower Respiratory Tract Dr T Avenant Recurrent or Persistent Pneumonia Definitions Recurrent pneumonia more than two episodes of pneumonia in 18 months Persistent pneumonia

More information

September 2008 [KT 168] Sub. Code: 2063 M.D. DEGREE EXAMINATION Branch XVII Tuberculosis and Respiratory Diseases NON-TUBERCULOSIS CHEST DISEASES Common to Part II Paper II - (Old /New/Revised Regulations)

More information

Table. Positive Purified Protein Derivative Results (Pediatrics In Review Apr 2008)

Table. Positive Purified Protein Derivative Results (Pediatrics In Review Apr 2008) PPD and TB Sreening COMPETENCY- The resident should know the risk factors for TB exposure, when to screen, and the appropriate criteria for recognizing a positive PPD in children of different age groups

More information

Health Protection Agency position statement on the use of Interferon Gamma Release Assay (IGRA) tests for Tuberculosis (TB)

Health Protection Agency position statement on the use of Interferon Gamma Release Assay (IGRA) tests for Tuberculosis (TB) Health Protection Agency position statement on the use of Interferon Gamma Release Assay (IGRA) tests for Tuberculosis (TB) Draft Interim HPA Guidance HPA Tuberculosis Programme Board Health Protection

More information

Massachusetts Department of Public Health Division of Global Populations and Infectious Disease Prevention

Massachusetts Department of Public Health Division of Global Populations and Infectious Disease Prevention Massachusetts Department of Public Health Division of Global Populations and Infectious Disease Prevention Screening Infants and Children for Tuberculosis in Massachusetts Executive Summary In Massachusetts,

More information

Curriculum. Diploma in Tuberculosis and Chest Diseases (DTCD) Bangabandhu Sheikh Mujib Medical University Shahbagh, Dhaka.

Curriculum. Diploma in Tuberculosis and Chest Diseases (DTCD) Bangabandhu Sheikh Mujib Medical University Shahbagh, Dhaka. Curriculum Diploma in Tuberculosis and Chest Diseases (DTCD) Bangabandhu Sheikh Mujib Medical University Shahbagh, Dhaka. 1 CONTENTS 1. Name of the course 3 2. Duration 3 3. Date of commencement 3 4. Aims

More information

CDC TB Testing Guidelines and Recent Literature Update

CDC TB Testing Guidelines and Recent Literature Update Pocket Guide QuantiFERON -TB Gold CDC TB Testing Guidelines and Recent Literature Update Using IGRAs for TB screening in your patients June 2010 A full copy of the US Centers for Disease Control and Prevention

More information

Pediatric Latent TB Diagnosis and Treatment

Pediatric Latent TB Diagnosis and Treatment Date Updated: April 2015 Guidelines Reviewed: 1. CDC Latent TB Guidelines 2. Harborview Pediatric Clinic Latent TB Management, 2010 3. Pediatric Associates Latent TB Guidelines, 2013 4. Seattle Children

More information

Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015

Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015 Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015 2 Objectives Participants will be able to : Understand the Pathogenesis of Tuberculosis (TB) Identify the Goals of Public Health for TB Identify Hierarchy

More information

SPONTANEOUS PNEUMOTHORAX AS A COMPLICATION OF SEPTIC PULMONARY EMBOLISM IN AN INTRAVENOUS DRUG USER: A CASE REPORT

SPONTANEOUS PNEUMOTHORAX AS A COMPLICATION OF SEPTIC PULMONARY EMBOLISM IN AN INTRAVENOUS DRUG USER: A CASE REPORT Spontaneous pneumothorax in an IV drug user SPONTANEOUS PNEUMOTHORAX AS A COMPLICATION OF SEPTIC PULMONARY EMBOLISM IN AN INTRAVENOUS DRUG USER: A CASE REPORT Chau-Chyun Sheu, Jhi-Jhu Hwang, Jong-Rung

More information

Varicella and Varicella Vaccine

Varicella and Varicella Vaccine Varicella and Epidemiology and Prevention of Vaccine- Preventable Diseases Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at http://www.vaccineinformation.org/photos/index.asp

More information

Childhood Tuberculosis Some Basic Issues. Jeffrey R. Starke, M.D. Baylor College of Medicine

Childhood Tuberculosis Some Basic Issues. Jeffrey R. Starke, M.D. Baylor College of Medicine Childhood Tuberculosis Some Basic Issues Jeffrey R. Starke, M.D. Baylor College of Medicine TUBERCULOSIS IS A SOCIAL DISEASE WITH MEDICAL IMPLICATIONS THE GREAT PARADOX OF TUBERCULOSIS A CAUTIONARY TALE

More information

Controversies in Hospital Medicine: Antifungal Therapy. Empiric Therapy, Combination Therapy, and the Question of Central Venous Catheters

Controversies in Hospital Medicine: Antifungal Therapy. Empiric Therapy, Combination Therapy, and the Question of Central Venous Catheters Controversies in Hospital Medicine: Antifungal Therapy Empiric Therapy, Combination Therapy, and the Question of Central Venous Catheters Douglas Fish, Pharm.D. Professor of Pharmacy, University of Colorado

More information

Immunology Platform 2012

Immunology Platform 2012 Immunology Platform 2012 The scientific activity report of Immunology Platform of the Institut Pasteur du Cambodge for the period January 1st to December 31st, 2012. Scientific activity report Prepared

More information

Key Facts about Influenza (Flu) & Flu Vaccine

Key Facts about Influenza (Flu) & Flu Vaccine Key Facts about Influenza (Flu) & Flu Vaccine mouths or noses of people who are nearby. Less often, a person might also get flu by touching a surface or object that has flu virus on it and then touching

More information

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges John B. Kaneene, DVM, MPH, PhD University Distinguished Professor of Epidemiology Director, Center for Comparative Epidemiology

More information

Guideline. Treatment of tuberculosis in patients with HIV co-infection. Version 3.0

Guideline. Treatment of tuberculosis in patients with HIV co-infection. Version 3.0 Guideline Treatment of tuberculosis in patients with HIV co-infection Version 3.0 Key critical points Co-infection with Tuberculosis (TB) and HIV is common in many parts of the world, especially sub-saharan

More information

Recent Advances in The Treatment of Mycobacterium Tuberculosis

Recent Advances in The Treatment of Mycobacterium Tuberculosis Recent Advances in The Treatment of Mycobacterium Tuberculosis Dr Mohd Arif Mohd Zim Senior Lecturer & Respiratory Physician Faculty of Medicine, Universiti Teknologi MARA mohdarif035@salam.uitm.edu.my

More information

Diagnosis and management of community acquired pneumonia in children

Diagnosis and management of community acquired pneumonia in children Diagnosis and management of community acquired pneumonia in children an Robinson Relationships with commercial interests: Grants/Research Support: NIH, Pfizer Speakers Bureau/Honoraria: None Consulting

More information

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

BACKGROUND MEDIA INFORMATION Fast facts about liver disease BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of

More information

Influenza (Flu) Influenza is a viral infection that may affect both the upper and lower respiratory tracts. There are three types of flu virus:

Influenza (Flu) Influenza is a viral infection that may affect both the upper and lower respiratory tracts. There are three types of flu virus: Respiratory Disorders Bio 375 Pathophysiology General Manifestations of Respiratory Disease Sneezing is a reflex response to irritation in the upper respiratory tract and is associated with inflammation

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Do statins improve outcomes of patients with sepsis and pneumonia? Jordi Carratalà Department of Infectious Diseases Statins for sepsis & community-acquired pneumonia Sepsis and CAP are major healthcare

More information

The Global Alliance against Chronic Respiratory Diseases

The Global Alliance against Chronic Respiratory Diseases The Global Alliance against Chronic Respiratory Diseases Pulmonary hypertension Dr Marc Humbert What is the burden of pulmonary hypertension? The true burden of pulmonary hypertension is currently unknown

More information

Clinical description 2 Laboratory test for diagnosis 3. Incubation period 4 Mode of transmission 4 Period of communicability 4

Clinical description 2 Laboratory test for diagnosis 3. Incubation period 4 Mode of transmission 4 Period of communicability 4 Tuberculosis Contents Epidemiology in New Zealand 2 Case definition 2 Clinical description 2 Laboratory test for diagnosis 3 Case classification 3 Spread of infection 4 Incubation period 4 Mode of transmission

More information

X-Plain Pediatric Tuberculosis Reference Summary

X-Plain Pediatric Tuberculosis Reference Summary X-Plain Pediatric Tuberculosis Reference Summary Introduction Tuberculosis, or TB, is a bacterial infection that causes more deaths in the world than any other infectious disease. When a child gets TB,

More information

Risk for Tuberculosis in Swiss Hospitals. Content. Introduction. Dr. med. Alexander Turk Zürcher Höhenklinik Wald alexander.turk@zhw.

Risk for Tuberculosis in Swiss Hospitals. Content. Introduction. Dr. med. Alexander Turk Zürcher Höhenklinik Wald alexander.turk@zhw. Risk for Tuberculosis in Swiss Hospitals 17. Tuberkulose Symposium Münchenwiler Risk for Tuberculosis in Swiss Hospitals Dr. med. Alexander Turk Zürcher Höhenklinik Wald alexander.turk@zhw.ch 1 Content

More information

GRANIX (tbo-filgrastim)

GRANIX (tbo-filgrastim) RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil

More information

Tuberculosis Exposure Control Plan for Low Risk Dental Offices

Tuberculosis Exposure Control Plan for Low Risk Dental Offices Tuberculosis Exposure Control Plan for Low Risk Dental Offices A. BACKGROUND According to the CDC, approximately one-third of the world s population, almost two billion people, are infected with tuberculosis.

More information

Nevada State Health Division Technical Bulletin

Nevada State Health Division Technical Bulletin Nevada State Health Division Technical Bulletin Topic: Using QuantiFERON and Tuberculin Skin Test to Screen for TB Section/Program/Contact: Bureau of Community Health / Tuberculosis Program / Susanne Paulson,

More information

Surgery for MDR/XDR Tuberculosis and Non-Tuberculous Mycobacterial Disease

Surgery for MDR/XDR Tuberculosis and Non-Tuberculous Mycobacterial Disease Surgery for MDR/XDR Tuberculosis and Non-Tuberculous Mycobacterial Disease John D. Mitchell, M.D. Professor and Chief Section of General Thoracic Surgery Davis Endowed Chair in Thoracic Surgery University

More information

Fungal Infections: When Broad Spectrum Antibiotics Aren t Broad Enough

Fungal Infections: When Broad Spectrum Antibiotics Aren t Broad Enough Fungal Infections: When Broad Spectrum Antibiotics Aren t Broad Enough Minor fungal infections are encountered often in the ED, but fungal infections can also be much more than a nuisance. Life-threatening

More information

Curriculum vitae. Safy Zahid Kaddah. Assistant professor of chest diseases department, Cairo University.

Curriculum vitae. Safy Zahid Kaddah. Assistant professor of chest diseases department, Cairo University. Curriculum vitae Safy Zahid Kaddah Assistant professor of chest diseases department, Cairo University. The chest diseases department coordinate of the technical support office for projects and grants Kasr

More information

AMBULATORY TREATMENT AND PUBLIC HEALTH MEASURES FOR A PATIENT WITH UNCOMPLICATED PULMONARY TUBERCULOSIS

AMBULATORY TREATMENT AND PUBLIC HEALTH MEASURES FOR A PATIENT WITH UNCOMPLICATED PULMONARY TUBERCULOSIS AMBULATORY TREATMENT AND PUBLIC HEALTH MEASURES FOR A PATIENT WITH UNCOMPLICATED PULMONARY TUBERCULOSIS (UPDATE 2004) Internal guidelines of the Tuberculosis & Chest Service of the Department of Health

More information

Components of CVC Care Bundle. selection

Components of CVC Care Bundle. selection Components of CVC Care Bundle Catheter site selection Site of insertion influences the subsequent risk for CR-BSI and phlebitis The influence of site is related in part to the risk for thrombophlebitis

More information

Original article: Sumito Inoue*, Yoko Shibata, Noriaki Takabatake, Akira Igarashi, Shuichi Abe, Isao Kubota

Original article: Sumito Inoue*, Yoko Shibata, Noriaki Takabatake, Akira Igarashi, Shuichi Abe, Isao Kubota Original article: INFLUENCE OF CORTICOSTEROID THERAPY ON THE SERUM ANTIBODY RESPONSE TO INFLUENZA VACCINE IN ELDERLY PATIENTS WITH CHRONIC PULMONARY DISEASES Sumito Inoue*, Yoko Shibata, Noriaki Takabatake,

More information

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection Module 1 Overview of HIV Infection Purpose Pre-requisite Modules Learning Objectives To provide you with the basic terms and concepts related to HIV infection. None At the end of this module, you will

More information

Emerging Infectious Disease (4): Drug-Resistant Tuberculosis

Emerging Infectious Disease (4): Drug-Resistant Tuberculosis S67 Drug-Resistant Tuberculosis Emerging Infectious Disease (4): Drug-Resistant Tuberculosis Chi-Fang You, MD; Han-Ping Ma, MD; Tzong-Luen Wang, MD, PhD; Aming Chor-Min Lin, MD Abstract Before the discovery

More information

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Chapter 1 Overview of Tuberculosis Epidemiology in the United States Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States.... 3 TB Disease Trends in the United

More information

TB preventive therapy in children. Introduction

TB preventive therapy in children. Introduction TB preventive therapy in children H S Schaaf Department of Paediatrics and Child Health, and Desmond Tutu TB Centre Stellenbosch University, and Tygerberg Children s Hospital Introduction Children are

More information

Antimicrobial Therapy in Immunocompromised and Critically Ill Patients: Management and Perspectives Palazzo dei Congressi - LUGANO 29-30 May 2014

Antimicrobial Therapy in Immunocompromised and Critically Ill Patients: Management and Perspectives Palazzo dei Congressi - LUGANO 29-30 May 2014 Antimicrobial Therapy in Immunocompromised and Critically Ill Patients: Management and Perspectives Palazzo dei Congressi - LUGANO 29-30 May 2014 BACKGROUND The incidence and diagnosis of viral, bacterial

More information

Chapter 3 Testing for Tuberculosis Infection and Disease

Chapter 3 Testing for Tuberculosis Infection and Disease Chapter 3 Testing for Tuberculosis Infection and Disease Table of Contents Chapter Objectives.... 45 Introduction.... 47 Identifying High-Risk Groups for M. tuberculosis Testing... 47 Testing Methods for

More information

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection L14: Hospital acquired infection, nosocomial infection Definition A hospital acquired infection, also called a nosocomial infection, is an infection that first appears between 48 hours and four days after

More information

Clinical Scenarios In Childhood TB. Josefina Cadorna Carlos M.D., FPPS, FPIDSP, FSMID Associate Professor of Pediatrics U E R M M M C

Clinical Scenarios In Childhood TB. Josefina Cadorna Carlos M.D., FPPS, FPIDSP, FSMID Associate Professor of Pediatrics U E R M M M C Clinical Scenarios In Childhood TB Josefina Cadorna Carlos M.D., FPPS, FPIDSP, FSMID Associate Professor of Pediatrics U E R M M M C Objectives: To present different commonly encountered clinical scenarios

More information

Management of Tuberculosis: Indian Guidelines

Management of Tuberculosis: Indian Guidelines Chapter 105 Management of Tuberculosis: Indian Guidelines Kuldeep Singh Sachdeva INTRODUCTION Tuberculosis (TB) is an infectious disease caused predominantly by Mycobacterium tuberculosis and among the

More information

WHO Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and other Influenza Viruses

WHO Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and other Influenza Viruses WHO Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and other Influenza Viruses 20 August 2009 Table of contents EXECUTIVE SUMMARY... i Other recommendations...iii 1. INTRODUCTION...

More information

Paediatrica Indonesiana. Limitations of the Indonesian Pediatric Tuberculosis Scoring System in the context of child contact investigation

Paediatrica Indonesiana. Limitations of the Indonesian Pediatric Tuberculosis Scoring System in the context of child contact investigation Paediatrica Indonesiana VOLUME 51 November NUMBER 6 Original Article Limitations of the Indonesian Pediatric Tuberculosis Scoring System in the context of child contact investigation Rina Triasih 1,2,

More information

understanding the professional guidelines

understanding the professional guidelines SEVERE ASTHMA understanding the professional guidelines This guide includes information on what the European Respiratory Society (ERS) and the American Thoracic Society (ATS) have said about severe asthma.

More information

Aspergillus Azole resistance. Mecanisms of resistance. Origin of resistance

Aspergillus Azole resistance. Mecanisms of resistance. Origin of resistance Logo de la journée ici Etude prospective multicentrique (RADAR) de la résistance d Aspergillus fumigatus aux azolés en France J.B. MURAT 1,2, F. CHOUKRI 1, J.M. COSTA 3, I. ACCOCEBERRY 4, C. ANGEBAULT

More information

MAKE ANTIBODIES. Signs & Symptoms of Primary Immune Deficiency

MAKE ANTIBODIES. Signs & Symptoms of Primary Immune Deficiency Signs & Symptoms of Primary Immune Deficiency MAKE ANTIBODIES Dr Jovanka King Department of Allergy & Immunology Women s & Children s Hospital, Adelaide Overview Cook s tour of the immune system Signs

More information

Transient Hypogammaglobulinemia of Infancy. Chapter 7

Transient Hypogammaglobulinemia of Infancy. Chapter 7 Transient Hypogammaglobulinemia of Infancy Chapter 7 An unborn baby makes no IgG (antibody) and only slowly starts producing it after birth. However, starting at about the sixth month of pregnancy, the

More information

Pneumocystis Jiroveci: Imaging Findings on HRCT

Pneumocystis Jiroveci: Imaging Findings on HRCT Pneumocystis Jiroveci: Imaging Findings on HRCT Poster No.: C-2491 Congress: ECR 2015 Type: Educational Exhibit Authors: R. E. Correa Soto, J. M. Fernandez Garcia-Hierro, M. J. Martín 1 1 2 1 1 Sánchez,

More information

Management of a child failing first line TB treatment.

Management of a child failing first line TB treatment. Management of a child failing first line TB treatment. Robert Gie Desmond Tutu Tuberculosis Centre Department of Paediatric and Child Health Stellenbosch University South Africa. Tygerberg Hospital Complex

More information

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200 GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung

More information

Epidemiological Studies on Environmental Stressors from Tobacco to Pesticides

Epidemiological Studies on Environmental Stressors from Tobacco to Pesticides Epidemiological Studies on Environmental Stressors from Tobacco to Pesticides W. Susan Cheng, PhD, MPH Rebecca Carlstrom, MPH Sukaina Hussain, MPH Healthy Lawn Symposium Oct 31, 2014 Two Presentations

More information

Prevention of Acute COPD exacerbations

Prevention of Acute COPD exacerbations December 3, 2015 Prevention of Acute COPD exacerbations George Pyrgos MD 1 Disclosures No funding received for this presentation I have previously conducted clinical trials with Boehringer Ingelheim. Principal

More information

SMALL CELL LUNG CANCER

SMALL CELL LUNG CANCER Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New

More information

COMPARISON OF MANTOUX AND QUANTIFERON-TB GOLD TEST FOR DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN ARMY PERSONNEL

COMPARISON OF MANTOUX AND QUANTIFERON-TB GOLD TEST FOR DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN ARMY PERSONNEL 2 COMPARISON OF MANTOUX AND QUANTIFERON-TB GOLD TEST FOR DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN ARMY PERSONNEL Willeke P.J. Franken 1, Joost F. Timmermans 2, Corine Prins 1, Evert-Jan H.J. Slootman

More information

Immuno-Oncology Therapies to Treat Lung Cancer

Immuno-Oncology Therapies to Treat Lung Cancer Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own

More information

Cytomegalovirus (HHV5/CMV) Roseolovirus (HHV6 & 7)

Cytomegalovirus (HHV5/CMV) Roseolovirus (HHV6 & 7) Betaherpesvirinae Cytomegalovirus (HHV5/CMV) Roseolovirus (HHV6 & 7) CYTOMEGALOVIRUS CMV is thought to be amongst the oldest type of herpesvirus in evolutionary terms. CMV is the prototype of beta-herpesviruses

More information

PET/CT Imaging in Lung Cancer

PET/CT Imaging in Lung Cancer PET/CT Imaging in Lung Cancer Mylene T. Truong, MD Mylene T. Truong M.D. Objectives To discuss the role of PET/CT in the staging of lung cancer To review the recommendations from American Society of Clinical

More information

Differentiating Asthma from COPD: Role of History, Physical Examination, Laboratory Studies, and Lung Function Testing

Differentiating Asthma from COPD: Role of History, Physical Examination, Laboratory Studies, and Lung Function Testing Differentiating Asthma from COPD: Role of History, Physical Examination, Laboratory Studies, and Lung Function Testing Stephen P Peters, MD, PhD, FAAAAI Professor of Medicine, Pediatrics and Translational

More information

Guidelines for TB Blood Testing. Minnesota Department of Health TB Prevention and Control Program June 2011

Guidelines for TB Blood Testing. Minnesota Department of Health TB Prevention and Control Program June 2011 Guidelines for TB Blood Testing Minnesota Department of Health TB Prevention and Control Program June 2011 Outline Interferon-Gamma Release Assays aka TB blood tests 1. What are they? 2. What are the current

More information

TB-HIV Co-Infection in Children. Reené Naidoo Paediatric HIV/TB Symposium August 2013

TB-HIV Co-Infection in Children. Reené Naidoo Paediatric HIV/TB Symposium August 2013 TB-HIV Co-Infection in Children Reené Naidoo Paediatric HIV/TB Symposium August 2013 Introduction TB & HIV are two of the leading causes of morbidity & mortality in children in South Africa HIV infection

More information

Perils and Pitfalls in Clinical Trials of Diagnostic Tests for Tuberculosis. Richard O Brien, MD Foundation for Innovative New Diagnostics Geneva

Perils and Pitfalls in Clinical Trials of Diagnostic Tests for Tuberculosis. Richard O Brien, MD Foundation for Innovative New Diagnostics Geneva Perils and Pitfalls in Clinical Trials of Diagnostic Tests for Tuberculosis Richard O Brien, MD Foundation for Innovative New Diagnostics Geneva 1 Outline of Presentation Statement of the problem Common

More information

Severe asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital

Severe asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital Severe asthma Definition, epidemiology and risk factors Mina Gaga Athens Chest Hospital Difficult asthma Defined as asthma, poorly controlled in terms of chronic symptoms, with episodic exacerbations,

More information

Lung and Lobar Lung Transplant

Lung and Lobar Lung Transplant Protocol Lung and Lobar Lung Transplant (70307) Medical Benefit Effective Date: 07/01/14 Next Review Date: 03/17 Preauthorization Yes Review Dates: 09/09, 09/10, 09/11, 07/12, 03/13, 03/14, 03/15, 03/16

More information

Self-Study Modules on Tuberculosis

Self-Study Modules on Tuberculosis Self-Study Modules on Tuberculosis Epidemiology of Tuberculosis U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD,

More information

TUBERCULOSIS SCREENING AND TREATMENT IN PREGNANCY. Stephanie N. Lin MD 2/12/2016

TUBERCULOSIS SCREENING AND TREATMENT IN PREGNANCY. Stephanie N. Lin MD 2/12/2016 TUBERCULOSIS SCREENING AND TREATMENT IN PREGNANCY Stephanie N. Lin MD 2/12/2016 Epidemiology of TB 9.6 million new cases in 2014 12% of them are in HIV positive patients 1.5 million deaths in 2014 ~646

More information

Your Guide to Express Critical Illness Insurance Definitions

Your Guide to Express Critical Illness Insurance Definitions Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses

More information

TB Prevention, Diagnosis and Treatment. Accelerating advocacy on TB/HIV 15th July, Vienna

TB Prevention, Diagnosis and Treatment. Accelerating advocacy on TB/HIV 15th July, Vienna TB Prevention, Diagnosis and Treatment Accelerating advocacy on TB/HIV 15th July, Vienna Diagnosis Microscopy of specially stained sputum is the main test for diagnosing TB (1 2 days) TB bacilli seen in

More information

TB Intensive San Antonio, Texas November 11 14, 2014

TB Intensive San Antonio, Texas November 11 14, 2014 TB Intensive San Antonio, Texas November 11 14, 2014 TB in the HIV Patient Lisa Armitige, MD, PhD November 13, 2014 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interests

More information

Appendix E-- The CDC s Current and Proposed Classification System for HIV Infection

Appendix E-- The CDC s Current and Proposed Classification System for HIV Infection Appendix E-- The CDC s Current and Proposed Classification System for HIV Infection The Centers for Disease Control (CDC) has developed a classification system for human immunodeficiency virus (HIV) infection

More information

Challenges in Pediatric Tuberculosis. Mimi Emig, MD Spectrum Health Kent County Health Department

Challenges in Pediatric Tuberculosis. Mimi Emig, MD Spectrum Health Kent County Health Department Challenges in Pediatric Tuberculosis Mimi Emig, MD Spectrum Health Kent County Health Department Pediatric Tuberculosis: A Missed Public Health Opportunity Mimi Emig, MD Spectrum Health Kent County Health

More information

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors. Prof. Lester s BIOL 210 Practice Exam 4 (There is no answer key. Please do not email or ask me for answers.) Chapters 15, 16, 17, 19, HIV/AIDS, TB, Quorum Sensing 1) Siderophores are bacterial proteins

More information

San Francisco Treatment Guidelines for Latent Tuberculosis Infection

San Francisco Treatment Guidelines for Latent Tuberculosis Infection City and County of San Francisco Department of Public Health Tuberculosis Control Unit Julie Higashi, MD, PhD Director Population Health Division Edwin M. Lee Mayor Disease Prevention and Control Branch

More information

Aspergillosis. Case Study

Aspergillosis. Case Study Aspergillosis Fungus Ball Nadia Badar, Brandon Grant, Lauren O Bryon, Rusmieah Samad Aspergillosis is a disease of subcutaneous and deep mycoses caused by aspergillus fungus which usually affects the lungs.

More information

The Fatal Pulmonary Artery Involvement in Behçet s Disease

The Fatal Pulmonary Artery Involvement in Behçet s Disease The Fatal Pulmonary Artery Involvement in Behçet s Disease Dr. Vedat Hamuryudan Div. Rheumatology, Dept. Internal Medicine Cerrahpasa Medical Faculty, University of Istanbul 33 years old man Sept 2011:

More information

LEARNING OUTCOMES. Identify children at risk of developing TB disease. Correctly manage and refer children suspected of TB. Manage child contacts

LEARNING OUTCOMES. Identify children at risk of developing TB disease. Correctly manage and refer children suspected of TB. Manage child contacts TB in Children 1a TB IN CHILDREN 2 LEARNING OUTCOMES Identify children at risk of developing TB disease Correctly manage and refer children suspected of TB Manage child contacts 3 TB Infection and Disease

More information

Case Finding for Hepatitis B and Hepatitis C

Case Finding for Hepatitis B and Hepatitis C Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center

More information

Hepatitis C Glossary of Terms

Hepatitis C Glossary of Terms Acute Hepatitis C A short-term illness that usually occurs within the first six months after someone is exposed to the hepatitis C virus (HCV). 1 Antibodies Proteins produced as part of the body s immune

More information

Interesting Case Series. Periorbital Richter Syndrome

Interesting Case Series. Periorbital Richter Syndrome Interesting Case Series Periorbital Richter Syndrome MarkGorman,MRCS,MSc, a Julia Ruston, MRCS, b and Sarath Vennam, BMBS a a Division of Plastic Surgery, Royal Devon and Exeter Hospital, Exeter, Devon,

More information

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient

More information

Tuberculosis Prevention and Control Protocol, 2008

Tuberculosis Prevention and Control Protocol, 2008 Tuberculosis Prevention and Control Protocol, 2008 Preamble The Ontario Public Health Standards (OPHS) are published by the Minister of Health and Long- Term Care under the authority of the Health Protection

More information

Fungal Infection in Total Joint Arthroplasty. Dr.Wismer Dr.Al-Sahan

Fungal Infection in Total Joint Arthroplasty. Dr.Wismer Dr.Al-Sahan Fungal Infection in Total Joint Arthroplasty Dr.Wismer Dr.Al-Sahan Delayed Reimplantation Arthroplasty for Candidal Prosthetic Joint Infection: A Report of 4 Cases and Review of the Literature David M.

More information

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention National Center for HIV, STD, and TB Prevention Division of Tuberculosis Elimination Public

More information

This information explains the advice about tuberculosis (TB) that is set out in NICE guideline 33.

This information explains the advice about tuberculosis (TB) that is set out in NICE guideline 33. Tuberculosis: prevention, ention, diagnosis, management and service organisation Information for the public Published: 13 January 2016 nice.org.uk About this information NICE guidelines provide advice

More information

Lisa Y. Armitige, MD, PhD has the following disclosures to make:

Lisa Y. Armitige, MD, PhD has the following disclosures to make: Interferon Gamma Release Assays (IGRAs) Lisa Y. Armitige, MD, PhD May 13, 2015 TB for Pulmonologist Phoenix, AZ March 13, 2015 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has the following

More information

Journal of Infectious Diseases Advance Access published January 26, 2015

Journal of Infectious Diseases Advance Access published January 26, 2015 Journal of Infectious Diseases Advance Access published January 26, 2015 1 Effect of immune status on serial QuantiFERON-TB Gold In-Tube LTBI screening in persons with HIV in a low TB incidence country

More information

Originally published as:

Originally published as: Originally published as: Reuss, A.M., Wiese-Posselt, M., Weißmann, B., Siedler, A., Zuschneid, I., An Der Heiden, M., Claus, H., Von Kries, R., Haas, W.H. Incidence rate of nontuberculous mycobacterial

More information

Right-sided infective endocarditis:tunisian experience

Right-sided infective endocarditis:tunisian experience Right-sided infective endocarditis:tunisian experience L. Ammari, A. Ghoubontini, A. Berriche, R. Abdelmalek, S.Aissa, F.Kanoun, B.Kilani, H.Tiouiri Benaissa, T.Ben chaabane Department of Infectious diseases,

More information

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012 Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos

More information

Screening and preventive therapy for MDR/XDR-TB exposed/infected children (and adults)

Screening and preventive therapy for MDR/XDR-TB exposed/infected children (and adults) Screening and preventive therapy for MDR/XDR-TB exposed/infected children (and adults) H S Schaaf Department of Paediatrics and Child Health, and Desmond Tutu TB Centre Stellenbosch University, and Tygerberg

More information

Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer

Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer Dan Vogl Lay Abstract Early stage non-small cell lung cancer can be cured

More information

Lymphomas after organ transplantation

Lymphomas after organ transplantation Produced 21.03.2011 Revision due 21.03.2011 Lymphomas after organ transplantation People who have undergone an organ transplant are more at risk of developing lymphoma known as post-transplant lymphoproliferative

More information

Chapter 10 Human Immuno Deficiency Virus Infection

Chapter 10 Human Immuno Deficiency Virus Infection 143 Chapter 10 Human Immuno Deficiency Virus Infection Chapter 10 Human Immuno Deficiency Virus Infection...143 HIV infection...144 Clinical Features...146 Clinical Staging of HIV infection recommended

More information